Synthesis, anti-inflammatory, cyclooxygenases inhibitions assays and histopathological study of poly-substituted 1,3,5-triazines: Confirmation of regiospecific pyrazole cyclization by HMBC

被引:47
|
作者
Elshemy, Heba A. H. [1 ]
Abdelall, Eman K. A. [1 ]
Azouz, Amany A. [2 ]
Moawad, Abeer [3 ]
Ali, Waleed A. M. [4 ]
Safwat, Nesreen M. [5 ]
机构
[1] Beni Suef Univ, Dept Organ Pharmaceut Chem, Fac Pharm, Bani Suwayf 62514, Egypt
[2] Beni Suef Univ, Dept Pharmacol, Fac Pharm, Bani Suwayf 62514, Egypt
[3] Beni Suef Univ, Dept Pharmacognosy, Fac Pharm, Bani Suwayf 62514, Egypt
[4] Cairo Gen Hosp, Biochem Lab, Cairo, Egypt
[5] Beni Suef Univ, Dept Pathol, Fac Vet Med, Bani Suwayf 62514, Egypt
关键词
S-Triazines; COX-2; inhibitors; Anti-inflammatory activity; Enaminone; HMBC; Histopathology; CELECOXIB ANALOGS; RING FORMATION; 2D NMR; DERIVATIVES; 5-LIPOXYGENASE; PYRIMIDINE; LIABILITY; COX-2;
D O I
10.1016/j.ejmech.2016.12.030
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Three novel triazines series were prepared. These series are pyrazolines (4a and 4b), pyrazoles (6a, 6b and 8a-d) and isoxazoles (7a and 7b). Such series were designed as COX-2 inhibitors. All compounds were characterized by using spectroscopic methods and elemental analysis. Regarding COX-2, compounds 5b, 4a and 3b were the most active with IC50 in the range of 0.55-0.87 mu M. Most of synthesized compounds were relatively more potent to celecoxib (0.78 mu M), diclofenac (2.94 mu M) and indomethacin (7.24 mu M). A molecular modeling study was performed for the most active compounds. Histopathological evaluation also was done to estimate the safety of compounds. Finally, structure elucidation of pyrazole 8 was studied by 2D NMR. (C) 2016 Published by Elsevier Masson SAS.
引用
收藏
页码:10 / 21
页数:12
相关论文
共 7 条
  • [1] Synthesis of Novel Benzodifuranyl; 1,3,5-Triazines; 1,3,5-Oxadiazepines; and Thiazolopyrimidines Derived from Visnaginone and Khellinone as Anti-Inflammatory and Analgesic Agents
    Abu-Hashem, Ameen Ali
    Al-Hussain, Sami A.
    Zaki, Magdi E. A.
    MOLECULES, 2020, 25 (01):
  • [2] Design, synthesis of new anti-inflammatory agents with a pyrazole core: COX-1/COX-2 inhibition assays, anti-inflammatory, ulcerogenic, histopathological, molecular Modeling, and ADME studies
    Abdellatif, Khaled R. A.
    Abdelall, Eman K. A.
    Elshemy, Heba A. H.
    Lamie, Phoebe F.
    Elnahaas, Elshaymaa
    Amin, Dina M. E.
    JOURNAL OF MOLECULAR STRUCTURE, 2021, 1240
  • [3] Synthesis and antimicrobial, antiproliferative and anti-inflammatory activities of novel 1,3,5-substituted pyrazoline sulphonamides
    Thach, Thi-Dan
    Nguyen, T. My-Thao
    Nguyen, T. Anh-Thu
    Dang, Chi-Hien
    Luong, Thanh-Binh
    Dang, Van-Su
    Banh, Kien-Sam
    Luc, Van-Sieu
    Nguyen, Thanh-Danh
    ARABIAN JOURNAL OF CHEMISTRY, 2021, 14 (11)
  • [4] Synthesis and Pharmacological Investigation of 5-Substituted-3-methylsulfanyl-1H-pyrazole-4-carboxylic Acid Ethyl Esters as New Analgesic and Anti-inflammatory Agents
    Gokulan, P. D.
    Jayakar, B.
    Alagarsamy, V.
    Solomon, V. Raja
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2012, 62 (10): : 457 - 462
  • [5] Synthesis, cyclooxygenase inhibition and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing methanesulphonyl pharmacophore
    Abdellatif, Khaled R. A.
    Elsaady, Mohammed T.
    Abdel-Aziz, Salah A.
    Abusabaa, Ahmed H. A.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2016, 31 (06) : 1545 - 1555
  • [6] Synthesis and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing an aminosulphonyl pharmacophore
    Abdellatif, Khaled R. A.
    Abdelgawad, Mohamed A.
    Elshemy, Heba A. H.
    Alsayed, Shahinda S. R.
    Kamel, Gehan
    ARCHIVES OF PHARMACAL RESEARCH, 2015, 38 (11) : 1932 - 1942
  • [7] Design, Synthesis, Biological Evaluation, and Molecular Docking Study of 4,6-Dimethyl-5-aryl/alkyl-2-[2-hydroxy-3-(4-substituted-1-piperazinyl)propyl]pyrrolo[3,4-c]pyrrole-1,3(2H,5H)-diones as Anti-Inflammatory Agents with Dual Inhibition of COX and LOX
    Redzicka, Aleksandra
    Wiatrak, Benita
    Jeskowiak-Kossakowska, Izabela
    Kochel, Andrzej
    Placzek, Remigiusz
    Czyznikowska, Zaneta
    PHARMACEUTICALS, 2023, 16 (06)